PemBla: A Phase 1 study of intravesical pembrolizumab in recurrent non-muscle-invasive bladder cancer [0.03%]
派姆单抗膀胱内给药治疗复发性非肌层浸润性膀胱癌的I期研究（PEMBLA）
Victoria K Woodcock,Ji-Li Chen,Karin Purshouse et al.
Victoria K Woodcock et al.
Objectives: This study aimed to investigate the anti-PD-1 inhibitor pembrolizumab as a potential agent for use in non-muscle-invasive bladder cancer (NMIBC) by conducting a Phase 1 safety run-in study to assess the safety...
Clinical outcomes of anterior prostate cancers treated with robotic assisted radical prostatectomy [0.03%]
机器人辅助下前列腺癌根治术治疗前列腺前部癌的临床疗效分析
Reyan Saghir,Beth Russell,Francesca Kum et al.
Reyan Saghir et al.
Introduction: A prospective cohort study comparing peri- and postoperative outcomes for patients with predominantly anterior prostate cancer (APC) identified preoperatively against non-anterior prostate cancer (NAPC) trea...
Robotic-assisted versus laparoscopic nephroureterectomy; a systematic review and meta-analysis [0.03%]
机器人辅助与腹腔镜肾输尿管切除术的系统评价和meta分析研究
Niall J O&#x;Sullivan,Ailish Naughton,Hugo C Temperley et al.
Niall J O&#x;Sullivan et al.
Background: Upper tract urothelial carcinoma (UTUC) is the malignant transformation of urothelial cells, from the renal calyces to the ureteral orifices. While the benefits of minimally invasive nephroureterectomy over th...
Genomic alterations in neuroendocrine prostate cancer: A systematic review and meta-analysis [0.03%]
神经内分泌前列腺癌的基因组改变：系统性回顾和荟萃分析
Junru Chen,Mingchen Shi,Stephen Yiu Chuen Choi et al.
Junru Chen et al.
Background: Neuroendocrine prostate cancer (NEPC) is a lethal subtype of prostate cancer. We performed a systematic review and meta-analysis to evaluate the prevalence of genomic alterations in NEPC and better understand ...
The first SURS World Congress of Robotic Surgery at Mount Sinai Hospital in New York City: A tribute to the past and the future of robotic urologic surgery [0.03%]
纽约西奈山医院举行的首次全球机器人外科大会（SURS）：纪念过去的成就并展望机器人泌尿外科手术的未来
Raghav Gupta,Deepak Chopra,Ashok K Hemal et al.
Raghav Gupta et al.
Editorial
BJUI compass. 2023 Feb 14;4(3):243-245. DOI:10.1002/bco2.228 2023
Factors that influence preference for male or female urologist among underserved patients in New York City [0.03%]
纽约市未获得充分服务的患者选择男医生或女医生泌尿科医师的影响因素分析
Shirin Razdan,Patrick Ho,Christine Bieber et al.
Shirin Razdan et al.
Objective: To examine the prevalence of patient preference for male or female urologic provider and explore which patient characteristics influence this preference. ...
Salivary cotinine level and treatment response in muscle invasive bladder cancer: A pilot study [0.03%]
唾液可替宁水平与肌层浸润性膀胱癌治疗反应关系的前瞻性研究
Jeromy W Gotschall,C Kendall Major,Linda A Jacobs et al.
Jeromy W Gotschall et al.
Oncological and functional outcomes of organ-preserving cystectomy versus standard radical cystectomy: A systematic review and meta-analysis [0.03%]
保器官膀胱切除术与标准根治性膀胱切除术的肿瘤学及功能结果的系统评价和meta分析
Reece Clay,Raghav Shaunak,Siddarth Raj et al.
Reece Clay et al.
Introduction: Radical cystectomy (RC) is historically considered the gold standard treatment for muscle invasive and high-risk non-muscle invasive bladder cancer. However, this technique leaves the majority of patients of...
En bloc radical cystectomy: An overview of the technique and oncological results [0.03%]
整块膀胱全切术：技术及肿瘤学结果概述
Eirik Kjøbli,Øyvind Salvesen,Sverre Langørgen et al.
Eirik Kjøbli et al.
Objectives: To reduce recurrence after radical cystectomy (RC), we developed a technique based on the principles of the circumferential resection margin used during total mesorectal excision for rectal cancer, namely, en ...
Systematic review of reported association studies of monogenic genes and bladder cancer risk and confirmation analysis in a large population cohort [0.03%]
单基因与膀胱癌关联研究的系统综述及大人群队列的验证分析
Abrar Mian,Jun Wei,Zhuqing Shi et al.
Abrar Mian et al.
Objectives: To evaluate which of previously reported monogenic genes are associated with increased bladder cancer risk, we reviewed published papers on associations of genes and bladder cancer risk and performed a confirm...